These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pharmacology of the central cholinergic structures]. Votava Z Actual Pharmacol (Paris); 1966; 19():187-204. PubMed ID: 5340893 [No Abstract] [Full Text] [Related]
4. [Central effects of cholinomimetic and cholinolytic substances]. Holmstedt B Actual Pharmacol (Paris); 1970; 23():175-98. PubMed ID: 4948985 [No Abstract] [Full Text] [Related]
5. [Contribution to the study of the central effects of hallucinogenic and psychotomimetic medicines]. Longo VG Actual Neurophysiol (Paris); 1967; 7():203-16. PubMed ID: 6043096 [No Abstract] [Full Text] [Related]
6. Rating scale for autonomic, motor and central effects in dogs. Effects of anticholinergic and cholinergic drugs. Kabes J Act Nerv Super (Praha); 1972 Aug; 14(3):164-5. PubMed ID: 5052804 [No Abstract] [Full Text] [Related]
7. [Some differences in the effects of anticholinesterase compounds on nicotine and arecoline sensitivity in mice and rabbits]. Erkova AI; Savateev NV; Sofronov GA; Sherstobitov OE Dokl Akad Nauk SSSR; 1966 Apr; 167(5):1197-200. PubMed ID: 5996472 [No Abstract] [Full Text] [Related]
8. [From the field of neuropharmacology]. Herz A Nervenarzt; 1966 Oct; 37(10):451-4. PubMed ID: 6010486 [No Abstract] [Full Text] [Related]
9. [Pharmacologic study of an antihistaminic derived from dibenzothiazepine]. Allain P; Frossard J; Weber A; Chareton JY Therapie; 1969; 24(6):1011-26. PubMed ID: 4391606 [No Abstract] [Full Text] [Related]
10. [On the pharmacology of the active substances of betel. 1. Central effect of arecoline]. Nieschulz O Arzneimittelforschung; 1967 Oct; 17(10):1292-7. PubMed ID: 5632880 [No Abstract] [Full Text] [Related]
12. [Azoxodon, a central nervous system stimulator]. Polezhaeva AL Med Prom SSSR; 1966 Mar; 20(3):53-4. PubMed ID: 4383391 [No Abstract] [Full Text] [Related]
13. [Neurocoordinating effect of an oxazolinone, LD 3394]. Warot P; Petit H Lille Med; 1968; 13(6):Suppl 713-4. PubMed ID: 4879174 [No Abstract] [Full Text] [Related]
14. [On the pharmacology of 2,3-dioxybenzoic acid]. Polukordas G; Repchite M; Skublitskene G Farmakol Toksikol; 1966; 29(5):594-7. PubMed ID: 5995071 [No Abstract] [Full Text] [Related]
15. [Some indices of effect of acridine orange and proflavine on the central nervous system]. MashkovskiÄ MD; Polezhaeva AI Farmakol Toksikol; 1969; 32(1):25-8. PubMed ID: 5814163 [No Abstract] [Full Text] [Related]
16. [Experimental research on ethambutol toxicity on the central nervous system of various animals]. Grifa P; Jotti D; Benatti G G Ital Chemioter; 1967; 14(1):65-9. PubMed ID: 4985268 [No Abstract] [Full Text] [Related]
17. [On the effects on the central nervous system of sulpiride]. Laville C; Margarit J Therapeutique; 1969 May; 45(5):503-7. PubMed ID: 5791829 [No Abstract] [Full Text] [Related]
18. [Pharmacoligical study on 2-(O-chlorophenyl)-2-methylamino-cyclohexanone HC1 (CI-581), especially the effect on the central nervous system]. Shibuya T; Horibe M; Sasaki Y; Matsumiya T; Matsuda H Zasshi Tokyo Ika Daigaku; 1969; 27(2):249-56. PubMed ID: 5817870 [No Abstract] [Full Text] [Related]
19. [Methodical problems of psychopharmacology presented using the example of antidepressive agents]. Hoffmeister F Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796 [No Abstract] [Full Text] [Related]
20. Some central actions of potent muscarinic agent in lower vertebrates. Leslie GB; Ireson JD; Tattersall ML Comp Biochem Physiol; 1969 Nov; 31(4):571-4. PubMed ID: 5367354 [No Abstract] [Full Text] [Related] [Next] [New Search]